Heidelberg Pharma AG (HPHA):企業の財務・戦略的SWOT分析

◆英語タイトル:Heidelberg Pharma AG (HPHA) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH123319FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年1月
◆ページ数:52
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥33,750見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥50,625見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Heidelberg Pharma AG (HPHA) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Heidelberg Pharma AG (Heidelberg Pharma) is a biopharmaceutical company that develops novel therapeutics for the treatment and specific detection of various cancers. Heidelberg Pharma’s pipeline products are focused on treating multiple myeloma, prostate cancer, hematological cancers, non-hodgkin lymphoma, blood cancers, generic diseases and solid tumors. Through its subsidiary Heidelberg Pharma Research GmbH provides preclinical contract research services and is the first company to develop the toxin Amanitin into oncology therapies using its proprietary Antibody Targeted Amanitin Conjugate (ATAC) technology platform. Heidelberg Pharma is headquartered in Ladenburg, Germany.

Heidelberg Pharma AG Key Recent Developments

Oct 22,2020: Heidelberg Pharma contracts ProBioGen for cell line development and manufacturing services
Oct 08,2020: Heidelberg Pharma : Interim Management Statement on the First Nine Months of 2020
Sep 14,2020: Heidelberg Pharma receives milestone payment from Partner Magenta
Jul 09,2020: Heidelberg Pharma reports on first half-year 2020
Apr 23,2020: Heidelberg Pharma: Interim management statement on the first three months of 2020

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Heidelberg Pharma AG – Key Facts
Heidelberg Pharma AG – Key Employees
Heidelberg Pharma AG – Key Employee Biographies
Heidelberg Pharma AG – Major Products and Services
Heidelberg Pharma AG – History
Heidelberg Pharma AG – Company Statement
Heidelberg Pharma AG – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Heidelberg Pharma AG – Business Description
Business Segment: ADC Technology Sales Revenue
Performance
Business Segment: Out-licensing Sales Revenue
Performance
Business Segment: Service Business Sales Revenue
Capital Expenditure
Geographical Segment: Europe
Performance
Geographical Segment: Germany
Performance
Geographical Segment: Rest of the World
Performance
Geographical Segment: The US
Performance
Heidelberg Pharma AG – Corporate Strategy
Heidelberg Pharma AG – SWOT Analysis
SWOT Analysis – Overview
Heidelberg Pharma AG – Strengths
Heidelberg Pharma AG – Weaknesses
Heidelberg Pharma AG – Opportunities
Heidelberg Pharma AG – Threats
Heidelberg Pharma AG – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Heidelberg Pharma AG, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Heidelberg Pharma AG, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Heidelberg Pharma AG, Recent Deals Summary
Section 5 – Company’s Recent Developments
Oct 22, 2020: Heidelberg Pharma contracts ProBioGen for cell line development and manufacturing services
Oct 08, 2020: Heidelberg Pharma : Interim Management Statement on the First Nine Months of 2020
Sep 14, 2020: Heidelberg Pharma receives milestone payment from Partner Magenta
Jul 09, 2020: Heidelberg Pharma reports on first half-year 2020
Apr 23, 2020: Heidelberg Pharma: Interim management statement on the first three months of 2020
Mar 19, 2020: Heidelberg Pharma announces financial figures for fiscal year 2019 and provides business update
Mar 04, 2020: Heidelberg Pharma: US patent rights granted for diagnosis and treatment of patients with TP53/RNA polymerase II deletion
Jan 22, 2020: Heidelberg Pharma secures financing commitment from its main shareholder dievini
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Heidelberg Pharma AG, Key Facts
Heidelberg Pharma AG, Key Employees
Heidelberg Pharma AG, Key Employee Biographies
Heidelberg Pharma AG, Major Products and Services
Heidelberg Pharma AG, History
Heidelberg Pharma AG, Subsidiaries
Heidelberg Pharma AG, Key Competitors
Heidelberg Pharma AG, Ratios based on current share price
Heidelberg Pharma AG, Annual Ratios
Heidelberg Pharma AG, Annual Ratios (Cont...1)
Heidelberg Pharma AG, Interim Ratios
Heidelberg Pharma AG, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Heidelberg Pharma AG, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Heidelberg Pharma AG, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Heidelberg Pharma AG (HPHA):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • ArjoHuntleigh AB-医療機器分野:企業M&A・提携分析
    Summary ArjoHuntleigh AB (ArjoHuntleigh), a subsidiary of Getinge AB is a medical device company that offers hospital equipment. The company provides integrated solutions to help people affected by reduced mobility and make them self-sufficient. Its products include disinfection and hygiene systems, …
  • Guizhou Space Appliance Co., Ltd.:企業の戦略・SWOT・財務分析
    Guizhou Space Appliance Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Guizhou Space Appliance Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Yamana Gold Inc.:企業の戦略・SWOT・財務情報
    Yamana Gold Inc. - Strategy, SWOT and Corporate Finance Report Summary Yamana Gold Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Bankinter Banca Privada:企業の戦略・SWOT・財務情報
    Bankinter Banca Privada - Strategy, SWOT and Corporate Finance Report Summary Bankinter Banca Privada - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Nippon Soda Co Ltd (4041):企業の財務・戦略的SWOT分析
    Nippon Soda Co Ltd (4041) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Lanco Infratech Ltd (LITL):企業の財務・戦略的SWOT分析
    Lanco Infratech Ltd (LITL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Antitope Ltd:企業のM&A・事業提携・投資動向
    Antitope Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Antitope Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …
  • Hera SpA (HER):企業の財務・戦略的SWOT分析
    Hera SpA (HER) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • pSivida Corp (PSDV):製品パイプライン分析
    Summary pSivida Corp (pSivida) is a specialty pharmaceutical company that offers development of miniaturized, sustained-release drug delivery products and technologies. The company’s products include iluvien, retisert and durasert. Its durasert is an injectable, miniaturized, sustained-release drug …
  • New Gold Inc.:企業のM&A・事業提携・投資動向
    New Gold Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's New Gold Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments …
  • MinebeaMitsumi Inc:戦略・SWOT・企業財務分析
    MinebeaMitsumi Inc - Strategy, SWOT and Corporate Finance Report Summary MinebeaMitsumi Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Tristan Technologies Inc:企業の製品パイプライン分析2018
    Summary Tristan Technologies Inc (Tristan) is a medical device company that offers laboratory products. The company designs, develops and manufactures components and systems for biomagnetic measurement and clinical applications. Its products comprise biomagnetic devices, geomagnetic, cryogenic, non- …
  • Bangladesh Power Development Board-エネルギー分野:企業M&A・提携分析
    Summary Bangladesh Power Development Board (BPDB) is an integrated energy statutory board. It generates electricity through owned power plants and procures electricity from public and private generation companies. The board utilizes gas, coal, hydro, furnace oil, and diesel as fuel source for electr …
  • Haitong Securities Co., Ltd.:戦略・SWOT・企業財務分析
    Haitong Securities Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Haitong Securities Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Renco Group SpA:企業の戦略的SWOT分析
    Renco Group SpA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Willis Lease Finance Corporation (WLFC):企業の財務・戦略的SWOT分析
    Willis Lease Finance Corporation (WLFC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Prestige Brands Holdings Inc (PBH):製薬・医療:M&Aディール及び事業提携情報
    Summary Prestige Brands Holdings Inc (Prestige) focuses on the marketing, sales and distribution of over-the-counter (OTC) healthcare and household cleaning brands. The company offers its products for digestive care; lice treatment, household cleaning; hygiene; oral care; pain relief; pediatric care …
  • Event Hospitality & Entertainment Ltd:企業の戦略・SWOT・財務情報
    Event Hospitality & Entertainment Ltd - Strategy, SWOT and Corporate Finance Report Summary Event Hospitality & Entertainment Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • AMAG Pharmaceuticals Inc (AMAG)-製薬・医療分野:企業M&A・提携分析
    Summary AMAG Pharmaceuticals Inc (AMAG) is a biopharmaceutical company that develops and commercializes specialty pharmaceutical products. The company focuses on maternal health, anemia management and cancer supportive care. Its major products include Makena (hydroxyprogesterone caproate injection) …
  • Microsoft Corporation (MSFT)-医療機器分野:企業M&A・提携分析
    Summary Microsoft Corporation (Microsoft) is a technology-based company that develops, licenses, and supports software products, services, and devices. The company offers a comprehensive range of operating systems, cross-device productivity applications, server applications, business solution applic …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆